+49 711 500 989 80
deen

Researchers unlock immune cell contributions that could lead to new therapies for endometrial cancer



Researchers unlock immune cell contributions that could lead to new therapies for endometrial cancer

Endometrial cancer is the most common cancer of the female reproductive system. Patients who have active immune responses against cancer cells tend to have better outcomes, but much of what is known focuses on only one type of immune cell called T cells. Researchers now provide insight on the role of B cell immunity in endometrial cancer.

Materials provided by H. Lee Moffitt Cancer Center & Research Institute. Note: Content may be edited for style and length.




Source link aaaaa

Related posts

30th June 2022

Research reveals structure of a human endogenous reverse transcriptase

Read more
30th June 2022

Shining some light on the obscure proteome

Read more
29th June 2022

Dynamic cells linked to brain tumor growth and recurrence

Read more